Indivior Pharmaceuticals INDV
NASDAQ INDV
$37.87 -1.17 (-3.00%)
At close: Aug 20, 2026 · 3:01 PM UTC

Indivior Pharmaceuticals (INDV) Share-based Compensation Growth (1y) (2025 - 2026)

Indivior Pharmaceuticals (INDV) Share-based Compensation Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn 5.26%
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -36.59%
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -0.11%
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -49.74%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -18.06%
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn 23.11%
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -65.00%
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Indivior Pharmaceuticals 4.51 Bn 4.29 Bn 294.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 200.00%
Dec 31, 2025 1,050.00%
Mar 31, 2025 -85.00%